Skip to main content
. Author manuscript; available in PMC: 2014 Jun 27.
Published in final edited form as: Pharmacotherapy. 2010 May;30(5):432–441. doi: 10.1592/phco.30.5.432

Table 1. Demographic and Blood Pressure Control Data.

Variable Intervention
Group
(n=296)
Control
Group
(n=288)
No. (%) of Patients

Male 115 (38.9) 129 (44.8)
Caucasian 256 (86.5) 237 (82.3)
Married 190 (64.2) 143 (49.7)a
Had insurance 279 (94.3) 269 (93.4)
Education beyond
 high schoolb
130/289 (45.0) 118/286 (41.3)
Household income 61/293 (20.8) 128/287 (44.6)c
 < $25,000b

Mean ± SD

Age (yrs) 58.2 ± 14.2 59.9 ± 13.2
No. of comorbid
 conditions
0.490 ± 0.75 0.774 ± 0.94d
No. of antihypertensive
 drugs
  Baseline 1.77 ±0.95 1.86 ± 0.92
  End of study 2.39 ± 0.97 2.20 ± 1.03
Blood pressure
 Systolic
  Baseline 153.3 ± 11.9 150.5 ± 12.9e
  End of study 129.7 ± 14.2 140.8 ±19.5f
 Diastolic
  Baseline 86.5 ± 11.9 84.1 ± 12.0g
  End of study 76.6 ± 10.7 78.9 ± 13.4h

Baseline data were compared between groups unless otherwise specified. Unless otherwise indicated, differences between groups were not statistically significant.

a

p=0.0004, χ2 test.

b

Data were not available for all patients.

c

p<0.0001, χ2 test.

d

p<0.0001, t test.

e

p=0.0070

f

p<0.0001

g

p=0.0149

h

p=0.032, t test.